Ibogaine Patents @ the USPO

Ibogaine Patents @ the United States Patent Office (USPO) Use of ibogaine in reducing excitotoxic brain damage Use of ibogaine in reducing excitotoxic brain damage This invention discloses that ibogaine, a plant derivative, can be used as a safe NMDA antagonist at relatively high dosages (including dosages high enough to…

Continue reading

Ibogaine Abstracts on PubMed

18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action. 18-MC, a novel iboga alkaloid congener, is being developed as a potential treatment for multiple forms of drug abuse. Like ibogaine (40 mg/kg), 18-MC…

Continue reading

Ibogaine 12-Methoxyibogamine Synthesis

Alexander Shulgin Reproduced by permission of author. (Original Publication: TiHKAL) There have been three total syntheses of ibogaine reported in the chemical literature. The first of these was a thirteen step process published about 30 years ago. Although the chemistry lab can serve a fine function for both isolation and…

Continue reading

The Bwiti Religion

The Bwiti Religion …and the psychoactive plant Tabernanthe iboga (Equatorial Africa) Giorgio Samorini Reproduced by Permission (Original Publication: Integration, 5: 105-114) The use of vegetable hallucinogens by humans for religious purposes is very ancient, probably even older than its use for healing, magic or teaching purposes. The profound alterations in…

Continue reading

Adam, Eve and Iboga

Iboga (Adam & Eve) Giorgio Samorini Reproduced by Permission (Original Publication: Integration, vol. 4, pp. 4-10) Abstract In this article, the author describes his personal experience in a Bwiti religious community of Northern Gabon, where Tabernanthe iboga, a powerful hallucinogenic plant, is used sacramentally. He believes that Bwiti represents one…

Continue reading

Ibogaine: Complex Pharmacokinetics…

Reprinted from Neurobiological Mechanisms of Drugs of Abuse Volume 914 of the Annals of the New York Academy of Sciences September 2000 Ibogaine: Complex Pharmacokinetics, Concerns for Safety, and Preliminary Efficacy Measures DEBORAH C. MASH,[a,b,h] CRAIG A. KOVERA,[o] JOHN PABLO,[o] RACHEL F. TYNDALE,[c] FRANK D. ERVIN,[d] IZBEN C. WILLIAMS,[e] EDWARD…

Continue reading

Ibogaine

2005 Ibogaine Conference: Alex Grey's Chapel of Sacred Mirrors (CoSM)

Ibogaine: The Whole Entire Everything (in its complete totality… partially) Copyright © 2005-2008, Patrick K. Kroupa All Rights Reserved “Everything is Poison. Nothing is Poison.” –Paracelsus “I saw the best minds of my generation destroyed by madness, starving hysterical naked, dragging themselves through the negro streets at dawn looking for…

Continue reading

London Ibogaine Conference: An In-depth Look

Copyright © 2002, Patrick K. Kroupa All Rights Reserved Original Publication: Heroin Times In the January issue of Heroin Times, I provided a brief summary of the topics which were covered at the second ibogaine conference in the U.K, which was held on December 12th 2001. This article provides a…

Continue reading